CSI Market
Sign In | Register

Celanese (CE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CE Annual Cash Flow →
Tracking cash flow results across Celanese to Mar 31 2025 helps illustrate how Mar 31 2026's cash generation has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income48.00
Depreciation & amortization208.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-80.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment48.00
Share-based Compensation-5.00
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions18.00
Financial Instruments and Foreign Currency Transaction0.00
Other Charges Gains Net Of Amounts Used-
Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash-2.00
Income taxes-3.00
Gain on Sale of Investments0.00
Increase (Decrease) in Receivables-203.00
Increase (Decrease) in Accounts Payable187.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Deferred Income Taxes-18.00
Other Working Capital-13.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-96.00
Discontinued operations-13.00
Net Cash flow from Operating Activities76.00
Investing Activities
Capital Expenditures-66.00
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Proceeds from Derivative Instrument, Investing Activities0.00
Deferred Proceeds On Plant Relocation-
Capital Expenditures Related To Plant Relocation-
Capital Expenditures Related To Ventures-
Payments For Proceeds From Sale Of Business And Assets Net-493.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Proceeds from Sale of Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-2.00
Other Net986.00
Discontinued operations0.00
Net Cash Flow from Investing Activities425.00
Financing Activities
Short-term debt Net-35.00
Other borrowing transactions0.00
Long-term debt - borrowings58.00
Long-term debt - repayments-15.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock-7.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-1,264.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents1,263.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-3.00
Net Cash Flow from Financing Activities-3.00
Effect of exchange rate on cash flow-3.00
Discontinued operations0.00
Free Cash Flow10.00
Total Cash Flow495.00
4 historic quarters locked

Sign in to unlock the full Celanese cash flow history.

Sign In Create Free Account

About Celanese Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 5, 2026
  • Source: ce-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001306830-26-000117

Figures are derived from filed reports and may be restated. Historical data is subject to revision.